The association between preoperative serum interleukin-6 levels and postoperative prognosis in patients with T2 gallbladder cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The association between preoperative serum interleukin-6 levels and postoperative prognosis in patients with T2 gallbladder cancer
Authors
Keywords
-
Journal
JOURNAL OF SURGICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-05-04
DOI
10.1002/jso.25085
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017
- (2017) Al B. Benson et al. Journal of the National Comprehensive Cancer Network
- Surgical treatment for gallbladder cancer – a systematic literature review
- (2017) Malin Sternby Eilard et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer
- (2016) M. S. Caetano et al. CANCER RESEARCH
- IL6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer
- (2016) Lei Wang et al. CANCER RESEARCH
- Effects of Surgical Methods and Tumor Location on Survival and Recurrence Patterns after Curative Resection in Patients with T2 Gallbladder Cancer
- (2016) Woohyun Jung et al. Gut and Liver
- Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis
- (2016) Bodo E. Lippitz et al. OncoImmunology
- Tumor Location Is a Strong Predictor of Tumor Progression and Survival in T2 Gallbladder Cancer
- (2015) Junichi Shindoh et al. ANNALS OF SURGERY
- IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study
- (2015) Jung-Ta Kao et al. BMC GASTROENTEROLOGY
- The Relationship Between Serum Interleukin-6 and the Recurrence of Hepatitis B Virus Related Hepatocellular Carcinoma after Curative Resection
- (2015) Tao Sheng et al. MEDICINE
- Versatile functions for IL-6 in metabolism and cancer
- (2015) Jan Mauer et al. TRENDS IN IMMUNOLOGY
- Siltuximab (CNTO 328): a promising option for human malignancies
- (2015) Bao-An Chen et al. Drug Design Development and Therapy
- Surgical Strategy for T1 Gallbladder Cancer: A Nationwide Multicenter Survey in South Korea
- (2014) Seung Eun Lee et al. ANNALS OF SURGICAL ONCOLOGY
- Surgical Strategy for T2 Gallbladder Cancer According to Tumor Location
- (2014) Huisong Lee et al. ANNALS OF SURGICAL ONCOLOGY
- Siltuximab in transplant-ineligible patients with myeloma
- (2014) Sanjeet Bagcchi LANCET ONCOLOGY
- Evaluation of Two Inflammation-Based Prognostic Scores in Patients with Resectable Gallbladder Carcinoma
- (2013) Xiang-Song Wu et al. ANNALS OF SURGICAL ONCOLOGY
- Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer
- (2013) S Mitsunaga et al. BRITISH JOURNAL OF CANCER
- Cytokine patterns in patients with cancer: a systematic review
- (2013) Bodo E Lippitz LANCET ONCOLOGY
- Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
- (2013) Xin Yao et al. PHARMACOLOGY & THERAPEUTICS
- IL-6 Expression Regulates Tumorigenicity and Correlates with Prognosis in Bladder Cancer
- (2013) Miao-Fen Chen et al. PLoS One
- A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer
- (2012) Gary Hudes et al. INVESTIGATIONAL NEW DRUGS
- Cancer-Related Inflammation
- (2012) Juliana Candido et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
- (2012) Pasquale Sansone et al. JOURNAL OF CLINICAL ONCOLOGY
- IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer
- (2011) M. S. Anglesio et al. CLINICAL CANCER RESEARCH
- The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study
- (2011) Jayaprakash Karkera et al. PROSTATE
- Systematic review on the surgical treatment for T1 gallbladder cancer
- (2011) Seung Eun Lee WORLD JOURNAL OF GASTROENTEROLOGY
- A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
- (2010) J-F Rossi et al. BRITISH JOURNAL OF CANCER
- Inflammation and Cancer: IL-6 and STAT3 Complete the Link
- (2009) Jacqueline Bromberg et al. CANCER CELL
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Surgical Outcomes and Prognostic Factors for T2 Gallbladder Cancer Following Surgical Resection
- (2009) Sae Byeol Choi et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Prognostic Factors for Gallbladder Cancer in Japan
- (2008) Masato Kayahara et al. ANNALS OF SURGERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search